HLA-DRB1 Protein (AA 27-264) (His tag)
-
- Target Alle HLA-DRB1 Proteine anzeigen
- HLA-DRB1 (Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 27-264
-
Spezies
- Maus
-
Quelle
- Escherichia coli (E. coli)
- Aufreinigungstag / Konjugat
- Dieses HLA-DRB1 Protein ist gelabelt mit His tag.
- Applikation
- SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC), Western Blotting (WB)
- Sequenz
- Val27-Ser264
- Produktmerkmale
- Recombinant HLA Class II Histocompatibility Antigen, DRB1 Beta Chain (HLA-DRB1), Prokaryotic expression, Val27-Ser264, N-terminal His Tag
- Reinheit
- >95 %
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Isoelectric Point:
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-80 °C
- Informationen zur Lagerung
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Haltbarkeit
- 12 months
-
- Target
- HLA-DRB1 (Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
- Andere Bezeichnung
- HLA Class II Histocompatibility Antigen, DRB1 Beta Chain (HLA-DRB1 Produkte)
- Synonyme
- MGC108235 Protein, DRB1 Protein, DRw10 Protein, HLA-DR1B Protein, HLA-DRB Protein, SS1 Protein, major histocompatibility complex, class II, DR beta 1 Protein, hla-drb1 Protein, HLA-DRB1 Protein
- Hintergrund
- HLA-DRB1, MHCDRb1, HLADRb1, Major Histocompatibility Complex Class II DR Beta 1, HLA Class II Histocompatibility Antigen,DRB1-9 Beta Chain, HLA class II histocompatibility antigen, DRB1-15 beta chain
- UniProt
- P01915
- Pathways
- T-Zell Rezeptor Signalweg, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, CXCR4-mediated Signaling Events, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-